The clinical trial for VAXINIA is open to all solid cancer, I see you are using @Mason14's misleading calculation. Some of these tumor might work more effective combined with CD19, we will find out "soon". So an IP reaching a registrational clinical trial is consider only $50-100M USD when you somehow had a target of $500M for just FPI for Ph1???
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $112.0M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.6¢ | 1.4¢ | $125.4K | 8.369M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 76 | 17029463 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 1061875 | 3 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |